Heineken proposes reappointment of Harold van den Broek as CFO
ProSilience HU58 provides the clinically supported digestive and immune benefits that consumers demand
Novozymes launched ProSilience HU58, a probiotic with superior stability and low cost-in-use that may help change the way America eats breakfast (and snacks and other meals).
85 per cent of U.S. consumers say they would be interested in getting probiotics through functional food and beverages, according to a recent survey, and ProSilience HU58 addresses this trend. The probiotic can withstand harsh processing conditions, allowing it to become an ingredient in entirely new food categories – for example breakfast cereal or coffee.
“ProSilience HU58 provides the clinically-supported digestive and immune benefits that consumers demand,” says Stephen Quinn, Novozymes Industry Manager, Functional Foods. “Its stability enables innovative products outside the dairy category, something important for pill-fatigued consumers who would prefer to get their probiotics in food rather than supplements.”
The new product is a part of Novozymes’ commitment to driving innovation in biosolutions and promoting healthy, sustainable food choices.
Traditional probiotics come with several challenges: they can be expensive, can create limitations in processing, and can suffer a shorter-than-expected shelf-life under the wrong conditions.
ProSilience HU58 solves these problems. It is a cost-effective, spore-forming probiotic that is more stable in food and beverage applications than the market leader. Manufacturers can be confident that the cell count in the product is the same as on the label at the expiration date.
The product has a rich and long heritage. Various strains of Bacillus subtilis have been used for centuries in traditional Eastern Asian and West African fermented foods.